|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the VNDA DEF 14A filed Apr 2, 2008. To Be Held On May 8,
2008
Dear Stockholder:
You are cordially invited to attend the Annual Meeting of
Stockholders of Vanda Pharmaceuticals Inc., a Delaware
corporation (the “Company”). The meeting will be held
on Thursday, May 8, 2008, at 9:00 a.m. local time at
9605 Medical Center Drive, Rockville, Maryland for the following
purposes:
To elect Mr. Richard W. Dugan and Dr. Brian K. Halak
to the Board of Directors, to serve as Class II directors
until the 2011 Annual Meeting of Stockholders.
To ratify the selection by the Audit Committee of
PricewaterhouseCoopers LLP as the independent registered public
accounting firm of the Company for the year ending
December 31, 2008.
To conduct any other business properly brought before the
meeting.
These items of business are more fully described in the Proxy
Statement accompanying this Notice.
The record date for the Annual Meeting is March 21, 2008.
Only stockholders of record at the close of business on that
date may vote at the meeting or any adjournment thereof.
William D. “Chip” Clark
Senior Vice President, Chief Business
Officer and Secretary
Rockville, Maryland
April 2, 2008
You are cordially invited to attend the meeting in person.
Whether or not you expect to attend the meeting, please
complete, date, sign and return the enclosed proxy card as
promptly as possible in order to ensure your representation at
the meeting. A return envelope (which is postage prepaid if
mailed in the United States) is enclosed for your convenience.
Even if you have voted by proxy, you may still vote in person if
you attend the meeting. Please note, however, that if your
shares are held of record by a broker, bank or other nominee and
you wish to vote at the meeting, you must obtain a proxy issued
in your name from that record holder.
This proxy statement and accompanying proxy are being
distributed on or about April 3, 2008
|
| |||||||
